Australia markets closed

bluebird bio, Inc. (BLE.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
15.900.00 (0.00%)
As of 05:13PM CEST. Market open.
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-594,158
-819,378
-618,695
-789,608
-555,625
Depreciation & amortisation
10,654
19,649
19,356
17,434
17,158
Stock-based compensation
75,526
127,915
156,631
160,629
110,836
Change in working capital
-34,403
17,985
-28,850
46,117
19,240
Inventory
-
-18,447
-
-
-
Accounts payable
636
9,286
-20,100
23,600
3,614
Other working capital
-524,953
-658,642
-499,337
-640,636
-469,163
Other non-cash items
11,639
17,622
-6,010
-8,253
-2,881
Net cash provided by operating activities
-506,318
-635,639
-470,351
-564,384
-413,426
Cash flows from investing activities
Investments in property, plant and equipment
-18,635
-23,003
-28,986
-76,252
-55,737
Purchases of investments
-255,246
-451,391
-1,003,525
-756,570
-1,517,982
Sales/maturities of investments
476,020
926,651
948,166
1,340,629
894,284
Net cash used for investing activities
312,439
562,557
-84,345
507,807
-679,435
Cash flows from financing activities
Debt repayment
-
-
0
0
-1,017
Common stock issued
83,018
74,975
541,536
0
703,852
Other financing activities
-
-174,284
-
-
-
Net cash used provided by (used for) financing activities
-90,103
-93,954
546,715
21,187
737,692
Net change in cash
-283,982
-167,036
-7,981
-35,390
-355,169
Cash at beginning of period
410,665
373,728
381,709
417,099
772,268
Cash at end of period
126,683
206,692
373,728
381,709
417,099
Free cash flow
Operating cash flow
-506,318
-635,639
-470,351
-564,384
-413,426
Capital expenditure
-18,635
-23,003
-28,986
-76,252
-55,737
Free cash flow
-524,953
-658,642
-499,337
-640,636
-469,163